COMP <GO>
ESAB vs RTX // 10Y YIELD & FRED MACRO BETA
ESAB Corporation (NYSE) VS. RTX Corporation (NYSE) • 15-METRIC TALLY: ESAB 7
— RTX 6
▲ 10Y YIELD & FRED MACRO BETA LEADER: RTX
LAST: $74.13 (+4.54%) • MKT CAP: $4.61B
macro-sensitivity
0.89
LAST: $199.40 (+1.82%) • MKT CAP: $269.08B
macro-sensitivity
0.92
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ESAB VS. RTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ESAB | RTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 36.90% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.10% | 7.20% | +2.90 | ESAB | /roic <GO> |
| EV/EBITDA & P/E Valuation | 12.5x | 26.5x | -14.00 | ESAB | /valuation <GO> |
| Free Cash Flow Yield | 4.63% | 2.95% | +1.68 | ESAB | /fcf-yield <GO> |
| Operating Margin | 14.50% | 10.50% | +4.00 | ESAB | /operating-margins <GO> |
| Net Profit Margin | 8.00% | 7.60% | +0.40 | ESAB | /net-margins <GO> |
| Revenue Growth (YoY) | 3.70% | 9.70% | -6.00 | RTX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.48% | 1.33% | -0.85 | RTX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.35 | 2.73 | -0.38 | RTX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | RTX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.3 | 60.0 | +0.30 | ESAB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.89 | 0.92 | -0.03 | RTX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.9x | 37.2x | -18.30 | ESAB | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.61B | $269.08B | -$264.47B | RTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ESAB REV | RTX REV | ESAB GROSS % | RTX GROSS % | ESAB FCF | RTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.84B | $88.60B | 36.9% | — | $213.3M | $7.94B |
| FY 2024 | $2.74B | $80.74B | 37.9% | — | $303.6M | $4.53B |
| FY 2023 | $2.77B | $68.92B | — | — | $205.6M | $4.78B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ESAB // BETA 0.89
RTX // BETA 0.92